Article ID Journal Published Year Pages File Type
6829722 Seizure 2018 14 Pages PDF
Abstract
VPA treatment increased the risk factors for the development of metabolic syndrome such as hyperinsulinemia, insulin resistance and oxidative stress. However VPA treatment corrected the dyslipidemia of epileptic patients.
Keywords
Related Topics
Life Sciences Neuroscience Behavioral Neuroscience
Preview
Biochemical derangements related to metabolic syndrome in epileptic patients on treatment with valproic acid
Authors
, , ,